425 related articles for article (PubMed ID: 26563392)
21. Curcumin diethyl disuccinate, a prodrug of curcumin, enhances anti-proliferative effect of curcumin against HepG2 cells via apoptosis induction.
Muangnoi C; Ratnatilaka Na Bhuket P; Jithavech P; Supasena W; Paraoan L; Patumraj S; Rojsitthisak P
Sci Rep; 2019 Aug; 9(1):11718. PubMed ID: 31406217
[TBL] [Abstract][Full Text] [Related]
22. Gender-related pharmacokinetics and absolute bioavailability of diosbulbin B in rats determined by ultra-performance liquid chromatography-tandem mass spectrometry.
Yang B; Wang X; Liu W; Zhang Q; Chen K; Ma Y; Wang C; Wang Z
J Ethnopharmacol; 2013 Oct; 149(3):810-5. PubMed ID: 23954278
[TBL] [Abstract][Full Text] [Related]
23. Improving the oral bioavailability of tapentadol via a carbamate prodrug approach: synthesis, bioactivation, and pharmacokinetics.
Li Y; Wang Y; Zhang R; Liu C; Wei Y; Sun J; He Z; Xu Y; Zhang T
Drug Deliv Transl Res; 2018 Oct; 8(5):1335-1344. PubMed ID: 29777509
[TBL] [Abstract][Full Text] [Related]
24. Tissue distribution & elimination of capsaicin, piperine & curcumin following oral intake in rats.
Suresh D; Srinivasan K
Indian J Med Res; 2010 May; 131():682-91. PubMed ID: 20516541
[TBL] [Abstract][Full Text] [Related]
25. Absorption and enterohepatic circulation of baicalin in rats.
Xing J; Chen X; Zhong D
Life Sci; 2005 Nov; 78(2):140-6. PubMed ID: 16107266
[TBL] [Abstract][Full Text] [Related]
26. Enhancement of the oral bioavailability of phenytoin by N-acetylation and absorptive characteristics.
Ogiso T; Tanino T; Kawaratani D; Iwaki M; Tanabe G; Muraoka O
Biol Pharm Bull; 1998 Oct; 21(10):1084-9. PubMed ID: 9821815
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetics and disposition of the novel dopamine agonist Z-7760 in rat after intravenous and oral administration.
Bollard M; Caldwell J; Taylor GW; Strolin-Benedetti M; Semeraro C
Xenobiotica; 2000 Oct; 30(10):983-91. PubMed ID: 11315106
[TBL] [Abstract][Full Text] [Related]
28. Single Dose Oral and Intravenous Pharmacokinetics and Tissue Distribution of a Novel Hesperetin Derivative MTBH in Rats.
Shen C; Qian Z; Chen R; Meng X; Hu T; Chen Z; Li Y; Huang C; Hu C; Li J
Eur J Drug Metab Pharmacokinet; 2016 Dec; 41(6):675-688. PubMed ID: 26254910
[TBL] [Abstract][Full Text] [Related]
29. Disposition of a low dose of 14C-bisphenol A in male rats and its main biliary excretion as BPA glucuronide.
Kurebayashi H; Betsui H; Ohno Y
Toxicol Sci; 2003 May; 73(1):17-25. PubMed ID: 12700409
[TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetics and metabolism of SL-01, a prodrug of gemcitabine, in rats.
Zhao C; Li Y; Qin Y; Wang R; Li G; Sun C; Qu X; Li W
Cancer Chemother Pharmacol; 2013 Jun; 71(6):1541-50. PubMed ID: 23564376
[TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetic evaluation of 3'-azido-2', 3'-dideoxyuridine-5'-O-valinate-hydrochloride as a prodrug of the anti-HIV nucleoside 3'-azido-2', 3'-dideoxyuridine.
Kong L; Cooperwood JS; Huang SH; Chu CK; Boudinot FD
Antivir Chem Chemother; 2003 Sep; 14(5):263-70. PubMed ID: 14694989
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetics and tissue distribution of hydrazinocurcumin in rats.
Satyavert ; Gupta S; Choudhury H; Jacob S; Nair AB; Dhanawat M; Munjal K
Pharmacol Rep; 2021 Dec; 73(6):1734-1743. PubMed ID: 34283375
[TBL] [Abstract][Full Text] [Related]
33. Characterization of metabolites of the chemopreventive agent curcumin in human and rat hepatocytes and in the rat in vivo, and evaluation of their ability to inhibit phorbol ester-induced prostaglandin E2 production.
Ireson C; Orr S; Jones DJ; Verschoyle R; Lim CK; Luo JL; Howells L; Plummer S; Jukes R; Williams M; Steward WP; Gescher A
Cancer Res; 2001 Feb; 61(3):1058-64. PubMed ID: 11221833
[TBL] [Abstract][Full Text] [Related]
34. Bioavailability of the amino acid-attached prodrug as a new anti-HIV agent in rats.
Chae KA; Cho HJ; Sung JM; Lee H; Seo DC; Kim JS; Shin HC
J Vet Sci; 2007 Sep; 8(3):263-7. PubMed ID: 17679773
[TBL] [Abstract][Full Text] [Related]
35. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K
Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
[TBL] [Abstract][Full Text] [Related]
36. In vitro stability and in vivo pharmacokinetic studies of a model opioid peptide, H-Tyr-D-Ala-Gly-Phe-D-Leu-OH (DADLE), and its cyclic prodrugs.
Yang JZ; Chen W; Borchardt RT
J Pharmacol Exp Ther; 2002 Nov; 303(2):840-8. PubMed ID: 12388671
[TBL] [Abstract][Full Text] [Related]
37. The effects of dose, route, and repeated dosing on the disposition and kinetics of tetrabromobisphenol A in male F-344 rats.
Kuester RK; Sólyom AM; Rodriguez VP; Sipes IG
Toxicol Sci; 2007 Apr; 96(2):237-45. PubMed ID: 17234645
[TBL] [Abstract][Full Text] [Related]
38. A novel prodrug approach for tertiary amines. 3. In vivo evaluation of two N-phosphonooxymethyl prodrugs in rats and dogs.
Krise JP; Charman WN; Charman SA; Stella VJ
J Pharm Sci; 1999 Sep; 88(9):928-32. PubMed ID: 10479356
[TBL] [Abstract][Full Text] [Related]
39. Dose-escalation and pharmacokinetic study of nanoparticle curcumin, a potential anticancer agent with improved bioavailability, in healthy human volunteers.
Kanai M; Imaizumi A; Otsuka Y; Sasaki H; Hashiguchi M; Tsujiko K; Matsumoto S; Ishiguro H; Chiba T
Cancer Chemother Pharmacol; 2012 Jan; 69(1):65-70. PubMed ID: 21603867
[TBL] [Abstract][Full Text] [Related]
40. Characterization of the pharmacokinetics of dioscin in rat.
Li K; Tang Y; Fawcett JP; Gu J; Zhong D
Steroids; 2005 Jul; 70(8):525-30. PubMed ID: 15894036
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
